ENTRY       D12307                      Drug
NAME        Pivekimab (USAN)
FORMULA     C6476H10034N1720O2031S46
EXACT_MASS  145866.1905
MOL_WEIGHT  145956.2586
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYIFT SSIMHWVRQA PGQGLEWIGY IKPYNDGTKY
            NEKFKGRATL TSDRSTSTAY MELSSLRSED TAVYYCAREG GNDYYDTMDY WGQGTLVTVS
            SASTKGPSVF PLAPSSKSTS GGTAALGCLV KDYFPEPVTV SWNSGALTSG VHTFPAVLQS
            SGLYSLSSVV TVPSSSLGTQ TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG
            GPSVFLFPPK PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY
            NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP QVYTLPPSRD
            ELTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP VLDSDGSFFL YSKLTVDKSR
            WQQGNVFSCS VMHEALHNHY TQKSLCLSPG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCRASQDIN SYLSWFQQKP GKAPKTLIYR VNRLVDGVPS
            RFSGSGSGND	YTLTISSLQP EDFATYYCLQ YDAFPYTFGQ GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H148-H204, H224-L214, H230-H'230, H233-H'233, H265-H325, H371-H429, H'22-H'96, H'148-H'204, H'224-L'214, H'265-H'325, H'371-H'429, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastiv, Anti-IL3 receptor antibody
  TYPE      Monoclonal antibody
TARGET      IL3RA (CD123) [HSA:3563] [KO:K04737]
  PATHWAY   hsa04060(3563)  Cytokine-cytokine receptor interaction
            hsa04151(3563)  PI3K-Akt signaling pathway
            hsa04630(3563)  JAK-STAT signaling pathway
            hsa04640(3563)  Hematopoietic cell lineage
            hsa05200(3563)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL3RA (CD123)
                 D12307  Pivekimab (USAN)
DBLINKS     CAS: 2234335-84-1
///
